13 Jobs
Flagship Pioneering is Hiring an AI Intern Near Cambridge, MA
Key Responsibilities:
- Learn Flagship Pioneering’s system of generating and refining actionable pioneering hypotheses
- Contribute to the development of ML models and AI tools that accelerate scientific research and the origination of new companies
- Build LLM-enabled agents for biological data access, management, transformation, and analysis
- Iterate with internal end users to deliver an effective user experience
- Work directly with highly experienced Flagship Pioneering team members—a group of innovative and experienced scientists, entrepreneurs, and executives
- Explore full-time opportunities at Flagship Pioneering and our AI/ML-focused companies
- Currently enrolled in a PhD program in Biology, Computer Science, Machine Learning, Applied Mathematics, or a related field.
- Deep research experience in at least one of the following fields: machine learning, modeling and simulation, computational biology
- Record of scientific and academic excellence and creativity in the ability to solve complex scientific problems
- A passion for innovation and a willingness to explore uncharted territories.
Job Summary
Intern
$123k-158k (estimate)
05/07/2024
05/20/2024
flagshippioneering.com
CAMBRIDGE, MA
500 - 1,000
2000
VOLKER HERRMANN
$50M - $200M
Business Services
Related Companies
About Flagship Pioneering
Flagship Pioneering conceives, creates, resources, and develops first-in-category life sciences companies to transform human health and sustainability. Since its launch in 2000, the firm has applied a unique, hypothesis-driven innovation process to originate and foster more than 100 scientific ventures, resulting in over $30 billion in aggregate value. To date, Flagship is backed by >$3 billion of aggregate capital commitments, of which over $1.5 billion has been deployed toward the founding and growth of its pioneering companies alongside >$10 billion of follow-on investments from other insti ...
tutions. The current Flagship ecosystem includes Denali Therapeutics (NASDAQ: DNLI), Evelo Biosciences (NASDAQ: EVLO), Moderna Therapeutics (NASDAQ: MRNA), Rubius Therapeutics (NASDAQ: RUBY), Seres Therapeutics (NASDAQ: MCRB), and Syros Pharmaceuticals (NASDAQ: SYRS).
More
Show Less
